HCWB HCW Biologics Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$1.36
Price · May 20, 2026
Fundamentals as of Mar 31, 2026

HCWB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.36
Market Cap
P/E (TTM)
-0.1
EPS (TTM)
$-10.63
Revenue (TTM)
$54.2K
Div Yield
ROE
-586.8%
Debt/Equity
2.5
52W Range
$0 – $9

HCWB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $54.2K
6-point trend, -98.7%
2020-12-31 2025-12-31
EPS $-10.63
5-point trend, -1440.6%
2021-12-31 2025-12-31
Free Cash Flow $-13M
5-point trend, -21.5%
2021-12-31 2025-12-31
Margins -14677.1%
4-point trend, -48.0%
2022-12-31 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
HCWB
Peer Median
P/E (TTM)
5-point trend, +99.9%
-0.1

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
HCWB
Peer Median
Gross Margin
4-point trend, -48.0%
20.0%
51.4%
Operating Margin
4-point trend, -10719.7%
-24270.7%
Net Profit Margin
4-point trend, -6521.2%
-14677.1%
-403.8%
ROA
4-point trend, +22.1%
-29.1%
-105.2%
ROE
4-point trend, -2300.1%
-586.8%
-155.0%
ROIC
4-point trend, -426.5%
-137.5%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
HCWB
Peer Median
Debt / Equity
3-point trend, +140.8%
2.5
0.0
Current Ratio
4-point trend, -99.4%
0.1
2.8
Quick Ratio
4-point trend, -99.4%
0.1

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
HCWB
Peer Median
Revenue YoY
5-point trend, +54232.00
-97.9%
Revenue CAGR 3Y
5-point trend, +54232.00
-79.9%
Revenue CAGR 5Y
5-point trend, +54232.00
-57.9%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
HCWB
Peer Median
EPS (Diluted)
5-point trend, -1440.6%
$-10.63

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
HCWB
Peer Median

HCWB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-05-14
Median target $2.00 +47.0%
Mean target $2.00 +47.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-2.9%
Period EPS Actual EPS Est Surprise
March 31, 2026 $0.37 $-0.45 0.82%
Dec. 31, 2025 $-3.19 $-0.86 -2.3%
Sept. 30, 2025 $-2.02 $-2.35 0.33%
June 30, 2025 $-1.08 $1.84 -2.9%
Dec. 31, 2024 $-3.20 $3.67 -6.9%
Dec. 31, 2023 $-12.00 $-5.71 -6.3%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
GOVX $296.2K -37.1% -862.3% -645.9%
ACXP $6M -0.5 -180.3%
BIAF
XBIO -1.4 19.0%
BCAB -0.6
SILO $5M -0.7 0.00% -5863.5% -75.3% 38.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 17
Annual Income Statement data for HCWB
Metric Trend 202520242023202220212020
Revenue 6-point trend, -98.7% $54.2K $3M $3M $7M $0 $4M
Cost of Revenue 5-point trend, +43386.00 $43.4K $2M $2M $4M $0 ·
Gross Profit 5-point trend, +10846.00 $10.8K $959.4K $560.4K $3M $0 ·
R&D Expense 6-point trend, -25.0% $5M $6M $8M $9M $8M $7M
SG&A Expense 6-point trend, +188.5% $8M $7M $7M $8M $5M $3M
Operating Expenses 6-point trend, +32.7% $13M $30M $26M $18M $13M $10M
Operating Income 6-point trend, -126.0% $-13M $-29M $-26M $-15M $-13M $-6M
Interest Expense 5-point trend, +845051.00 $845.1K $654.3K $283.0K $126.7K $0 ·
Other Non-op 2-point trend, +100.0% $0 $-1M · · · ·
Pretax Income 6-point trend, -37.2% $-8M $-30M $-25M $-15M $-13M $-6M
Income Tax Flat — no change across 6 periods $0 $0 $0 $0 $0 $0
Net Income 6-point trend, -37.2% $-8M $-30M $-25M $-15M $-13M $-6M
EPS (Basic) 5-point trend, -1440.6% $-10.63 $-30.96 $-0.70 $-0.42 $-0.69 ·
EPS (Diluted) 5-point trend, -1440.6% $-10.63 $-30.96 $-0.70 $-0.42 $-0.69 ·
Shares (Basic) 5-point trend, -88.8% 2,097,701 969,825 35,929,446 35,822,249 18,770,935 ·
Shares (Diluted) 5-point trend, -88.8% 2,097,701 969,825 35,929,446 35,822,249 18,770,935 ·
EBITDA 5-point trend, +5.5% $-12M $-28M $-25M $-14M $-13M ·
Balance Sheet 24
Annual Balance Sheet data for HCWB
Metric Trend 202520242023202220212020
Cash & Equivalents 6-point trend, -76.9% $2M $5M $4M $22M $12M $8M
Short-term Investments 5-point trend, -100.0% $0 $0 $0 $10M $25M ·
Receivables 6-point trend, -98.7% $32.2K $582.2K $2M $417.7K $133.0K $2M
Prepaid Expense 6-point trend, -58.7% $222.2K $328.2K $1M $1M $2M $538.3K
Other Current Assets 6-point trend, -88.1% $77.6K $113.5K $230.9K $196.0K $1M $654.5K
Current Assets 6-point trend, -81.2% $2M $6M $6M $34M $40M $12M
PP&E (Net) 6-point trend, +1192.6% $21M $23M $20M $11M $1M $2M
PP&E (Gross) 6-point trend, +821.7% $25M $27M $23M $13M $3M $3M
Accum. Depreciation 6-point trend, +278.9% $4M $4M $3M $2M $2M $1M
Other Non-current Assets 6-point trend, -16.8% $28.5K $28.5K $56.5K $333.9K $393.3K $34.2K
Total Assets 6-point trend, +59.2% $25M $30M $29M $47M $54M $15M
Accounts Payable 6-point trend, +8360.9% $13M $22M $6M $1M $223.7K $155.3K
Short-term Debt 3-point trend, +6809215.00 $7M $6M $0 · · ·
Current Liabilities 6-point trend, +2004.0% $21M $30M $9M $3M $2M $1M
Capital Leases · · · $14.3K · ·
Deferred Tax 4-point trend, +24897.00 $24.9K $40.9K $146.9K $0 · ·
Total Liabilities 5-point trend, +837.1% $22M $37M $15M $9M $2M ·
Long-term Debt 5-point trend, +0.00 $0 $7M $6M $6M $0 ·
Total Debt 4-point trend, -82.2% $7M $6M $119.4K $38M · ·
Common Stock 5-point trend, -90.8% $328 $111 $3.6K $3.6K $3.6K ·
Paid-in Capital 6-point trend, +111280287.00 $111M $94M $84M $83M $82M $0
Retained Earnings 6-point trend, -549.1% $-109M $-101M $-71M $-46M $-31M $-17M
Stockholders' Equity 6-point trend, +116.5% $3M $-7M $13M $37M $51M $-17M
Liabilities + Equity 6-point trend, +59.2% $25M $30M $29M $47M $54M $15M
Cash Flow 14
Annual Cash Flow data for HCWB
Metric Trend 202520242023202220212020
D&A 6-point trend, +81.9% $1M $1M $1M $717.9K $543.6K $572.9K
Stock-based Comp 6-point trend, +3413.7% $768.6K $1M $1M $1M $361.0K $21.9K
Other Non-cash 5-point trend, -837.4% $-7M $14M $341.2K $3M $982.2K ·
Operating Cash Flow 6-point trend, -28.4% $-13M $-14M $-23M $-10M $-11M $-10M
CapEx 6-point trend, -100.0% $0 $261.6K $6M $10M $47.3K $186.7K
Investing Cash Flow 6-point trend, +100.0% $0 $-261.6K $4M $15M $-35M $-186.7K
Debt Issued 2-point trend, -100.0% · · · · $0 $563.6K
Net Debt Issued · · · · $0 ·
Stock Issued 6-point trend, +55396.9% $5M $6M $23.7K $15.8K $29.5K $9.9K
Net Stock Activity 5-point trend, +18503.0% $5M $6M $23.7K $15.8K $29.5K ·
Financing Cash Flow 6-point trend, -8.9% $11M $16M $-14.5K $6M $49M $12M
Net Change in Cash 6-point trend, -347.5% $-3M $1M $-19M $11M $3M $1M
Free Cash Flow 5-point trend, -21.5% $-13M $-14M $-29M $-21M $-11M ·
Levered FCF 3-point trend, +31.5% $-14M $-15M · $-21M · ·
Profitability 8
Annual Profitability data for HCWB
Metric Trend 202520242023202220212020
Gross Margin 4-point trend, -48.0% 20.0% 37.4% 19.7% 38.5% · ·
Operating Margin 4-point trend, -10719.7% -24270.7% -1148.5% -905.0% -224.3% · ·
Net Margin 4-point trend, -6521.2% -14677.1% -1169.7% -879.5% -221.7% · ·
Pretax Margin 4-point trend, -6521.2% -14677.1% -1169.7% -879.5% -221.7% · ·
EBITDA Margin 4-point trend, -10361.4% -22349.8% -1102.4% -865.0% -213.6% · ·
ROA 4-point trend, +22.1% -29.1% -102.2% · -29.7% -37.3% ·
ROE 4-point trend, -2300.1% -586.8% 358.7% · -37.3% -24.4% ·
ROIC 4-point trend, -426.5% -137.5% 6472.1% · -19.9% -26.1% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for HCWB
Metric Trend 202520242023202220212020
Current Ratio 4-point trend, -99.4% 0.1 0.2 · 11.5 17.4 ·
Quick Ratio 4-point trend, -99.4% 0.1 0.2 · 11.0 15.9 ·
Debt / Equity 3-point trend, +140.8% 2.5 -0.9 · 1.0 · ·
Interest Coverage 4-point trend, +86.9% -15.6 -46.7 -90.9 -119.0 · ·
Efficiency 2
Annual Efficiency data for HCWB
Metric Trend 202520242023202220212020
Asset Turnover 3-point trend, -98.5% 0.0 0.1 · 0.1 · ·
Receivables Turnover 3-point trend, -99.3% 0.2 2.4 · 24.4 · ·
Per Share 3
Annual Per Share data for HCWB
Metric Trend 202520242023202220212020
Revenue / Share 4-point trend, -86.2% $0.03 $0.07 $0.08 $0.19 · ·
Cash Flow / Share 4-point trend, -2102.1% $-6.38 $-0.37 $-0.63 $-0.29 · ·
EPS (TTM) 5-point trend, -1440.6% $-10.63 $-30.96 $-0.70 $-0.42 $-0.69 ·
Growth Rates 3
Annual Growth Rates data for HCWB
Metric Trend 202520242023202220212020
Revenue YoY 3-point trend, -69.6% -97.9% -9.7% -57.7% · · ·
Revenue CAGR 3Y 2-point trend, -595.1% -79.9% · -11.5% · · ·
Revenue CAGR 5Y -57.9% · · · · ·
Valuation (TTM) 4
Annual Valuation (TTM) data for HCWB
Metric Trend 202520242023202220212020
Revenue TTM 5-point trend, +54232.00 $54.2K $3M $3M $7M $0 ·
Net Income TTM 5-point trend, +38.1% $-8M $-30M $-25M $-15M $-13M ·
P/E 5-point trend, +99.9% -0.1 -0.6 -70.0 -182.4 -134.5 ·
Earnings Yield 5-point trend, -147839.2% -1094.8% -173.5% -1.4% -0.55% -0.74% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $54.2K$3M$3M$7M$0
Gross Margin % 20.0%37.4%19.7%38.5%
Operating Margin % -24270.7%-1148.5%-905.0%-224.3%
Net Income $-8M$-30M$-25M$-15M$-13M
Diluted EPS $-10.63$-30.96$-0.70$-0.42$-0.69
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 2.5-0.91.0
Current Ratio 0.10.211.517.4
Quick Ratio 0.10.211.015.9
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-13M$-14M$-29M$-21M$-11M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.